These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606 [TBL] [Abstract][Full Text] [Related]
4. Gaucher's disease: therapy by intravenous infusions of modified glucocerebrosidase. Beck M; Valadares ER; Lotz J Clin Investig; 1993 Jan; 71(1):78. PubMed ID: 8453266 [No Abstract] [Full Text] [Related]
5. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Shaaltiel Y; Bartfeld D; Hashmueli S; Baum G; Brill-Almon E; Galili G; Dym O; Boldin-Adamsky SA; Silman I; Sussman JL; Futerman AH; Aviezer D Plant Biotechnol J; 2007 Sep; 5(5):579-90. PubMed ID: 17524049 [TBL] [Abstract][Full Text] [Related]
6. Studies on the turnover of exogenous mannose-terminal glucocerebrosidase in rat liver lysosomes. Murray GJ; Oliver KL; Jin FS; Brady RO J Cell Biochem; 1995 Feb; 57(2):208-17. PubMed ID: 7759558 [TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase. Dale GL; Beutler E Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4672-4. PubMed ID: 1070017 [TBL] [Abstract][Full Text] [Related]
8. Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease. Séllos-Moura M; Barzegar S; Pan L; Shi P; Oommen S; Durant J; Ruiz JA J Immunol Methods; 2011 Oct; 373(1-2):45-53. PubMed ID: 21846471 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase. Mistry PK; Davies S; Corfield A; Dixon AK; Cox TM Q J Med; 1992 Jul; 83(303):541-6. PubMed ID: 1484931 [TBL] [Abstract][Full Text] [Related]
10. Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase. Richards SM; Olson TA; McPherson JM Blood; 1993 Sep; 82(5):1402-9. PubMed ID: 8364193 [TBL] [Abstract][Full Text] [Related]
11. Glucocerebrosidase for treatment of Gaucher's disease: first German long-term results. Niederau C; Holderer A; Heintges T; Strohmeyer G J Hepatol; 1994 Oct; 21(4):610-7. PubMed ID: 7814809 [TBL] [Abstract][Full Text] [Related]
12. Alglucerase. A review of its therapeutic use in Gaucher's disease. Whittington R; Goa KL Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912 [TBL] [Abstract][Full Text] [Related]
13. Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: induction of humoral tolerance in seroconverted patients after repeat administration. Rosenberg M; Kingma W; Fitzpatrick MA; Richards SM Blood; 1999 Mar; 93(6):2081-8. PubMed ID: 10068682 [TBL] [Abstract][Full Text] [Related]
14. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy. Mazher W; Ali J; Abubakar S; Basar S; Murtaza G J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391 [TBL] [Abstract][Full Text] [Related]